Nasdaq GlobeNewswire

Perceptive Automata announces $16M in Series A funding led by JAZZ Venture Partners to advance human intuition for self-driving cars

Del

Toyota and Hyundai also participated in the startup’s funding round

SOMERVILLE, Mass., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Perceptive Automata, the leading provider of human behavior prediction software for machines, announced today that it has raised $16 million in Series A funding. The oversubscribed round was led by JAZZ Venture Partners with participation from Toyota AI Ventures, Hyundai Motor Company, and existing investors First Round Capital and Slow Ventures, among others. The investment brings Perceptive Automata’s total capital to $20 million.

This funding round brings together investors with a shared vision for how to solve the human behavior prediction challenge for machines. Lead investor JAZZ Venture Partners backs world-class teams working at the intersection of neuroscience and digital technology, which perfectly describes Perceptive Automata and the company’s approach to equipping machines with human intuition.
  
Perceptive Automata’s software gives automated vehicles the ability to understand the state-of-mind of humans, pedestrians, cyclists, and other motorists. Automated vehicles need this capability to drive safely, smoothly, and predictably in a human-dominated road environment. The company is integrating its software with customer and partner ADAS and autonomous driving systems.

Perceptive Automata uses behavioral science techniques to characterize the way human drivers understand the states of the minds of other humans, and then trains its deep learning models to acquire that same ability. These sophisticated deep learning models output real-time data on the intention, awareness, and other state-of-mind attributes of pedestrians, cyclists, and other motorists. Customers’ autonomous driving systems can then assess the data to understand, for example, whether a stationary pedestrian wants to cross in front of the automated vehicle, if the cyclist ahead of the automated vehicle might want to turn left, or if another vehicle is about to merge lanes.

“We are extremely excited to invest in a company that is taking a behavioral science approach to developing AI that understands humans’ states of mind, as we believe there is no other way to solve this major challenge that is currently facing robotic systems,” said John Harris, co-founder and General Partner at JAZZ Venture Partners. Harris, who has years of experience building and running companies operating in highly regulated industries, will join Perceptive Automata’s Board of Directors. Phin Barnes from existing investor First Round Capital will also join as a Board Observer.

Toyota's first standalone venture capital firm, Toyota AI Ventures, is committed to advancing the safety of autonomous vehicles and improving the quality of human life through artificial intelligence. "Without the ability to understand and interact with humans on the road, autonomous vehicles cannot be safely deployed at any meaningful scale. That technology is essential for the broad adoption of self-driving cars and we're excited to back the team at Perceptive Automata," said Jim Adler, Founding Managing Director of Silicon Valley-based Toyota AI Ventures.

Hyundai Motor Co., the largest automobile manufacturer in South Korea, has been working on autonomous systems for many years and is partnering with companies such as Aurora and Baidu to develop and commercialize the technology. “Perceptive Automata is developing key artificial intelligence that can be applied to autonomous vehicles and robots, which will advance the self-driving ecosystem,” said John Suh, Vice President at Hyundai CRADLE, the corporate venturing and open innovation business of Hyundai Motor Co. “We were excited when we first learned about Perceptive Automata’s approach and we very much look forward to supporting the team’s efforts.”

“We are thrilled to have investors that understand the importance of the problem we are solving for machines and the approach we are taking,” said Sid Misra, co-founder and CEO of Perceptive Automata. “JAZZ, our lead investor, has a lot of experience building successful companies in regulated industries and, like us, focuses on the intersection of behavioral and computer science. Though they won’t have access to Perceptive Automata’s customer data, Toyota and Hyundai bring very valuable automotive industry and autonomous vehicle systems experience. They also share our longer-term interests in robotic systems outside automotive.”

The funding will be used to recruit engineering talent to further refine Perceptive Automata’s human intuition AI software for global markets and to grow the company’s product development and customer implementation teams.

About Perceptive Automata
Perceptive Automata is solving one of the hardest problems of automated driving: enabling vehicles to predict and understand human behavior to help safely achieve the large-scale rollout of highly-automated vehicles (L2/3) and fully-autonomous driving systems (L4/5). Perceptive Automata allows autonomous systems to anticipate human reactions so they can navigate safely and smoothly around pedestrians, cyclists, and other drivers. This is essential for autonomous systems to safely and seamlessly integrate into a human-dominated road environment and to enable a smooth ride experience for passengers of automated mobility services. For more information about Perceptive Automata, visit www.perceptiveautomata.com

About JAZZ Venture Partners
JAZZ Venture Partners invests in companies that extend the boundaries of human performance — improving how we live, learn, work, play, and experience the world. We seek breakthroughs at the intersection of cutting-edge neuroscience and digital technology that are in increasingly influencing the human experience, such as augmented reality, immersive gaming, artificial intelligence, machine learning, and closed-loop human-computer systems. JAZZ portfolio companies are unlocking human potential in broad markets, including health, mind-body wellness, accelerated learning, training, sports, entertainment, and the enterprise. For more information about JAZZ Venture Partners, visit www.jazzvp.com

About Toyota AI Ventures
Toyota AI Ventures is a Silicon Valley-based venture capital subsidiary of Toyota Research Institute (TRI) that invests in promising startups from around the world. The fund focuses on companies developing solutions in artificial intelligence (AI), robotics, autonomous mobility, data, and cloud technology that share its mission of improving the quality of human life through AI. For more information about Toyota AI Ventures, please visit www.toyota-ai.ventures

About Hyundai CRADLE
Hyundai CRADLE is the Center for Robotic-augmented Design in Living Experiences. CRADLE strengthens Hyundai Motor Group's core automotive business and expands it into new and adjacent markets with the goal of enhancing transportation on and off the road. The company also plans to expand the Hyundai CRADLE innovation concept globally. For more information about Hyundai CRADLE, visit www.cradleinc.com

Media Contact:
Rachel Chibidakis
press@perceptiveautomata.com

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

WillScot Announces Closing of Warrant Exchange Offer11.12.2018 22:05Pressemelding

BALTIMORE, Dec. 11, 2018 (GLOBE NEWSWIRE) -- WillScot Corporation (“WillScot”) (NASDAQ: WSC), the specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced the closing of its previously announced exchange offer (the “Exchange Offer”) relating to certain outstanding warrants issued in 2015 (the “Warrants”). Under the terms of the Exchange Offer, each Warrant holder had the opportunity to receive 0.18182 shares of WillScot Class A Common Stock, par value $0.0001 per share (“Common Stock”), for each Warrant tendered by the holder and exchanged pursuant to the Exchange Offer. As of the closing of the Exchange Offer on December 11, 2018, 45,131,827 outstanding Warrants were properly tendered and not withdrawn in the Exchange Offer. 45,031,827 of the Warrants tendered were public warrants, representing approximately 89% of the public warrants, and approximately 100,000 Warrants tendered were private warrant

DoubleVerify and InMobi Unite to Combat Mobile App Fraud11.12.2018 18:02Pressemelding

Partnership brings mobile app fraud prevention to advertisers globally NEW YORK, Dec. 11, 2018 (GLOBE NEWSWIRE) -- DoubleVerify ("DV"), the leading independent provider of marketing measurement software and analytics, today announced a partnership with InMobi, a global provider of enterprise platforms for marketers. As part of the partnership, DoubleVerify will provide always-on fraud filtering and measurement for mobile in-app advertising campaigns across the InMobi Exchange globally. The integration with InMobi covers pre-bid targeting for all InMobi Exchange impressions within the leading mobile in-app platform, as well as monitoring of post-bid fraud activity, such as spoofing – enabling InMobi to continuously refine the quality of its mobile ad inventory. “DV’s partnership with InMobi demonstrates our commitment to provide consistent, comprehensive quality coverage for global brand advertisers,” said Matt McLaughlin, COO at DoubleVerify. “With ad spend increasingly concentrated in

Claroty Announces Major Enhancements to Market-Leading Industrial Cybersecurity Platform11.12.2018 15:00Pressemelding

Groundbreaking multispectral data acquisition and network segmentation capabilities provide deeper OT network visibility and reduce risk for industrial enterprises and critical infrastructure providers NEW YORK, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Claroty, the leader in operational technology (OT) network protection, today announced several significant enhancements to its award-winning Continuous Threat Detection product and technology integrations with several leading industrial automation, network infrastructure and cybersecurity providers. Already the industry’s most complete industrial control systems (ICS) cybersecurity platform, this release incorporates new functionality to provide even more “extreme” visibility into ICS networks and help industrial enterprises decrease the risk of a cyberattack. The latest release of Claroty Continuous Threat Detection provides a large number of significant enhancements including: Virtual Zones and OT Network Segmentation – an innovative approach

INN Launches Battery Metals Channel11.12.2018 15:00Pressemelding

The new battery metals channel is designed to educate investors with original content and expert insight on the growing battery metals industry. VANCOUVER, British Columbia, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Investing News Network (INN) announces the launch of its battery metals channel. Responding to the growth and evolution of the battery metals market, this channel will host news, educational content and expert opinions on the lithium, cobalt, graphite, vanadium and manganese market segments. “INN has been a trusted source of information on the lithium, cobalt, graphite, vanadium and manganese markets for nearly a decade, and is excited to bring these sectors together under the battery metals umbrella,” said Nick Smith, CEO and publisher at INN. “Through connections with experts, our leading team of experienced writers creates original, insightful content on battery metals. INN educates investors in the industry by providing information they may never have access to on their own,” S

Galimedix Therapeutics Appoints Industry Veteran, Hermann Russ, M.D., Ph.D., Chief Scientific Officer11.12.2018 14:30Pressemelding

KENSINGTON, Md. and SHORASHIM, Israel, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Galimedix Therapeutics, which is developing new solutions for ophthalmic and neurodegenerative diseases, announced the appointment of Hermann Russ, M.D., Ph.D., as its chief scientific officer, effective December 1, 2018. Dr. Russ invented the use of the company’s lead molecule GAL-101/MRZ-99030 for the treatment of degenerative diseases of the retina, including glaucoma and dry macular degeneration. He is also co-inventor of the so-called “trigger effect” of GAL-101/MRZ-99030 and GAL-102/MRZ 14042, which is a unique reverse prion-like self-propagation mechanism of action important for the company’s eye drop and oral treatment regimens. “We are gratified that Dr. Russ is joining the Galimedix management team, as his knowledge in the field, as well as intimate experience with the compound, have already proven instrumental in the development of our company to date,” commented Andrew Pearlman, Ph.D., CEO of Galimedix

Farmako: Cannabis distributor to become gateway to Europe11.12.2018 10:00Pressemelding

Company is first to apply for a licence in the United Kingdom AAA-Team pushes to become gateway to Europe Company first to apply for distribution licences in UK Support of Canadian LP to obtain EU-GMP Focus on research and development FRANKFURT, Germany, Dec. 11, 2018 (GLOBE NEWSWIRE) -- The Frankfurt-based pharmaceutical company Farmako is a research-based pharmaceutical company that distributes medical cannabis. The company is active in all European markets that have created a legal basis for cannabinoid therapies. It is the first company for medical Cannabis pursue distribution licences in multiple European countries. Fort hat, it will rely on EU-GMP certified suppliers. The German market for medical cannabis is estimated at 19.1 million euros in 2018 and at 200 million Euros by 2019. For 2028, experts expect a market volume for medical cannabis of 7.8 billion euros in Germany, an increase by a factor of 400. The number of patients for cannabinoid therapies in Germany has grown from

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom